Inducible knockout of the interleukin-2 receptor α chain: Expression of the high-affinity IL-2 receptor is not required for the in vitro growth of HTLV-I-transformed cell lines

Virology

Volumn 237, Issue 2, 1997, Pages 209-216

  Richardson, Jennifer H ^a   Waldmann, Thomas A ^b   Sodroski, Joseph G ^a   Marasco, Wayne A ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Adult T cell leukemia; Cytokine receptors; Intrabody; Intracellular antibody; Single chain antibody; Tac

Indexed keywords

CELL SURFACE RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR;

ARTICLE; CELL GROWTH; CELL LINE; CELL TRANSFORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; IN VITRO STUDY; LEUKEMIA CELL; NONHUMAN; PRIORITY JOURNAL; T CELL LEUKEMIA; T LYMPHOCYTE;

HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0030698323     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8779     Document Type: Article

References (45)

1. Akagi T., Shimotohno K. Proliferative response of Tax1-transduced primary human T cells to anti-CD3 antibody stimulation by an interleukin-2-independent pathway. J. Virol. 67:1993;1211-1217.
2. Akagi T., Ohno H., Shimotohno K. Expression of cell-cycle regulatory genes in HTLV-I infected T-cell lines: Possible involvement of Tax1 in the altered expression of cyclin D2, p18Ink4 and p21Waf1/Cip1/Sdi1. Oncogene. 12:1996;1645-1652.
3. Arima N., Daitoku Y., Ohgaki S., Fukumori J., Tanaka H., Yamamoto Y., Fujimoto K., Onoue K. Autocrine growth of interleukin 2-producing leukemic cells in a patient with adult T cell leukemia. Blood. 68:1986;779-782.
4. Arya S. K., Wong-Staal F., Gallo R. C. T-cell growth factor gene: Lack of expression in human T-cell leukemia-lymphoma virus-infected cells. Science. 223:1984;1086-1087.
5. Cann A. J., Chen I. S. Y. Human T-cell leukemia virus types I and II. Virology. 1990;Raven Press, New York. p. 1501-.
6. Danial N. N., Pernis A., Rothman P. B. Jak-STAT signaling induced by the v-abl oncogene. Science. 269:1995;1875-1877.
7. Franchini G. Molecular mechanisms of Human T-cell Leukemia/Lymphotropic Virus Type 1 infection. Blood. 86:1995;3619-3639.
8. Franchini G., Wong-Staal F., Gallo R. C. Human T-cell leukemia virus (HTLV-I) transcripts in fresh and cultured cells of patients with adult T-cell leukemia. Proc. Natl. Acad. Sci. USA. 81:1984;6207-6211.
9. Gitlin S. D., Dittmer J., Reid R. L., Brady J. N. The molecular biology of human T-cell leukemia viruses. Cullen B. Frontiers in Molecular Biology. 1993;159-192 Oxford Univ. Press, Oxford.
10. Gouilleux-Gruart V., Gouilleux F., Desaint C., Claisse J-F., Capiod J-C., Delobel J., Weber-Nordt R., Dusanter-Fourt I., Dreyfus F., Groner B., Prin L. STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood. 87:1996;1692-1697.
11. Grassman R., Berchtold S., Radant I., Alt M., Fleckenstein M., Sodroski J. G., Haseltine W. A., Ramstedt U. Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture. J. Virol. 66:1992;4570-4575.
12. Grossen M., Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA. 89:1992;5547-5551.
13. Hattori T., Uchiyama T., Toibana T., Takatsuki T., Uchino H. Surface phenotype of Japanese adult T-cell leukemia cells characterized by monoclonal antibodies. Blood. 58:1981;645-647.
14. Hemar A., Subtil A., Lieb M., Morelon E., Hellio R. Endocytosis of interleukin 2 receptors in human T lymphocytes: Distinct intracellular localization and fate of the receptor a, b and g chains. J. Cell Biol. 129:1995;55-64.
15. Hori T., Uchiyama T., Tsudo M., Umadome H., Ohno H., Fukuhara S., Kita K., Uchino H. Establishment of an interleukin 2-dependent human T cell line from a patient with T cell chronic lymphocytic leukemia who is not infected with human T cell leukemia/lymphoma virus. Blood. 70:1987;1069-1072.
16. Hoshino H., Esumi H., Miwa M., Shimoyama M., Minato K., Tobinai K., Hirose M., Watanabe S., Inada N., Kinoshita K., Kamihira S., Ichimaru M., Sugimura T. Establishment and characterization of 10 cell lines derived from patients with adult T-cell leukemia. Proc. Natl. Acad. Sci. USA. 80:1983;6061-6065.
17. Inatsuki A., Yasukawa M., Kobayashi Y. Functional alterations of herpes simplex virus-specific CD4+ multifunctional T cell clones following infection with human T cell lymphotropic virus type I. J. Immunol. 143:1989;1327-1333.
18. Kanamori H., Suzuki N., Siomi H., Nosaka T., Sato A., Sabe H., Honjo T. HTLV-1 p27rex stabilizes human interleukin-2 receptor a chain mRNA. Embo J. 9:1990;4161-4166.
19. Kodaka T., Umadome H., Uchino H. Expression of cytokine mRNA in leukemic cells from adult T cell leukemia patients. Jpn. J. Cancer. Res. 80:1989;531-536.
20. Maeda M., Daitoku Y., Kashihara M., Okamoto H., Uchiyama T., Shirono K., Matsuoka M., Hattori T., Takatsuki K., Ikuta K., Shimizu A., Honjo T., Yodoi J. Evidence for the interleukin-2 dependent expansion of leukemic cells in adult T cell leukemia. Blood. 70:1987;1407-1411.
21. Maeda M., Shimizu A., Ikuta K., Okamoto H., Kashihara M., Uchiyama T., Honjo T., Yodoi J. Origin of human T-lymphotropic virus 1-positive T cell lines in adult T cell leukemia: Analysis of T cell receptor gene rearrangement. J. Exp. Med. 162:1985;2169-2174.
22. Meydan N., Grunberg T., Dadi H., Shahar M., Arpaia E., Lapidot Z., Leeder J. S., Freedman M., Cohen A., Gazit A., Levitzki A., Roifman C. M. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature. 379:1996;645-648.
23. Migone T. S., Lin J. X., Cereseto A., Mulloy J. C., O'Shea J. J., Franchini G., Leonard W. J. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science. 269:1995;79-81.
24. Minami Y., Kono T., Miyazaki T., Taniguchi T. The IL-2 receptor complex: its structure, function and target genes. Annu. Rev. Immunol. 11:1993;245-267.
25. Miyoshi I., Kubonishi I., Yoshimoto S., Akagi T., Ohtsuki Y., Shiraishi Y., Nagata K., Hinuma Y. Type C-virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature. 294:1981;770-771.
26. Mulloy J. C., Crowley R. W., Fullen J., Leonard W. J., Franchini G. The human T-cell leukemia/lymphotropic virus type 1 p12I protein binds the interleukin-2 receptor b and gc chains and affects their expression on the cell surface. J. Virol. 70:1996;3599-3605.
27. Popovic M., Lange-Wantzin G., Sarin P. S., Mann D., Gallo R. C. Transformation of human umbilical cord blood T cells by human T-cell leukemia/lymphoma virus. Proc. Natl. Acad. Sci. USA. 80:1983;5402-5406.
28. Richardson J. H., Marasco W. A. Intracellular antibodies: Development and therapeutic potential. Trends Biotechnol. 13:1995;306-310.
29. Richardson J. H., Sodroski J. G., Waldmann T. A., Marasco W. A. Phenotypic knockout of the high-affinity human interleukin 2 receptor by intracellular single-chain antibodies against the a subunit of the receptor. Proc. Natl. Acad. Sci. USA. 92:1995;3137-3141.
30. Richardson J. H., Lever A. M. L. HIV-1 Vectors. Karn J. HIV Techniques: A Practical Approach. 1995;89-113 IRL Press, Oxford.
31. Rubin L. A., Kurman C. C., Biddison W. E., Goldman N. D., Nelson D. L. A monoclonal antibody 7G7/B6, binds to an epitope on the human interleukin-2 (IL-2) receptor that is distinct from that recognized by IL-2 or anti-Tac. Hybridoma. 4:1985;91-102.
32. Salahuddin S. Z., Markham P. D., Wong-Staal F., Franchini G., Kalyanaraman V. S., Gallo R. C. Restricted expression of human T-cell leukemia-lymphoma virus (HTLV) in transformed human umbilical cord blood lines. Virology. 129:1983;51-64.
33. Sharon M., Gnarra J. R., Leonard W. J. The beta-chain of the IL-2 receptor (p70) is tyrosine-phosphorylated on YT and HUT-102B2 cells. J. Immunol. 143:1989;2530-2533.
34. Siekevitz M., Feinberg M. B., Holbrook N., Wong-Staal F., Greene W. C. Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T cell leukemia virus, type I. Proc. Natl. Acad. Sci. USA. 84:1987;5389-5393.
35. Smith K. A., Cantrell S. A. Interleukin 2 regulates its own receptors. Proc. Natl. Acad. Sci. USA. 82:1985;864-868.
36. Tendler C. L., Greenberg S. J., Blattner W. A., Manns A., Murphy E., Fleisher T., Hanchard B., Morgan O., Burton J. D., Nelson D. L., Waldmann T. A. Trans-activation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type 1-associated myelopathy: Pathogenic implications and a rationale for immunotherapy. Proc. Natl. Acad. Sci. USA. 87:1990;5218-5222.
37. Teshigawara K., Maeda M., Nishino K., Nikaido T., Uchiyama T., Tsudo M., Wano Y., Yodoi J. Adult T cell leukemia cells produce a lymphokine that augments interleukin 2 receptor expression. J. Mol. Cell. Immunol. 2:1985;17-22.
38. Uchiyama T., Broder S. A., Waldmann T. A. A monoclonal antibody reactive with activated and functionally mature human T-cells. J. Immunol. 126:1981;1393-1397.
39. Uchiyama T., Yodoi J., Sagawa K., Takatsuki K., Uchino H. Adult T cell leukemia: Clinical and hematologic features of 16 cases. Blood. 50:1977;481-492.
40. Uchiyama T., Hori T., Tsudo M., Wano Y., Umedomo H., Tamori S., Yodoi J., Maeda M., Sawami H., Uchino H. Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells. J. Clin. Invest. 76:1985;446-453.
41. Waldmann T. A., Greene W. C., Sarin P. S., Saxinger C., Blayney D. W., Blattner W. A., Goldman C. K., Bongiovanni K., Sharrow S., Depper J. M., Leonard W., Uchiyama T., Gallo R. C. Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sezary leukemia, and their distinction using anti-Tac monoclonal antibody identifying the human receptor for T cell growth factor. J. Clin. Invest. 73:1984;1711-1718.
42. Xu X., Kang S., Heidenreich O., Okerholm M., O'Shea J. J., Nerenberg M. I. Constitutive activation of different Jak kinases in human T cell leukemia virus type 1 (HTLV-I) Tax protein or virus-transformed cells. J. Clin. Invest. 96:1995;1548-1555.
43. Yodoi J., Uchiyama T. Diseases associated with HTLV-I: Virus, IL-2 receptor dysregulation and redox regulation. Immunol. Today. 13:1992;405-411.
44. Yodoi J., Uchiyama T., Maeda M. T cell growth factor receptor in adult T cell leukemia (correspondence). Blood. 62:1983;509-510.
45. Yssel H., Malefyt R., Duc Dodon M., Blanchard D., Gazzolo L., de Vries J., Spits H. Human T cell leukemia/lymphoma virus type I infection of a CD4+ proliferative/cytotoxic T cell clone progresses in at least two distinct phases based on changes in function and phenotype of the infected cells. J. Immunol. 142:1989;2279-2289.